Has Pasqal grown their patent portfolio through organic growth or acquisition? An IPO tells you the share price. It doesn't tell you who really invented what — or why Pasqal's own numbers don't quite add up.
Something interesting just happened in quantum computing patents Are we starting to see a more concentrated, IP-intensive group of companies emerge around quantum computing?
Xanadu's focused patent strategy to fault tolerant quantum computing First pure-play photonic quantum computing company goes public on Nasdaq. Following the public listing, Xanadu will focus on scaling its technology platform and advancing toward quantum computing applications that are useful and available to people everywhere.
Quantum Technology Companies: patent analysis - part III Background: Quantum computing patent applications have increased significantly since 2009, reflecting the growing maturity and industrial relevance of the field. Patent intelligence for people who don't read patents However, for those without a background in patents, or the means to access patent analytics, it’s not always clear
Quantum Technology Companies: patent analysis - part II Background: Quantum computing patent applications have increased significantly since 2009, reflecting the growing maturity and industrial relevance of the field. Patent intelligence for people who don't read patents However, for those without a background in patents, or the means to access patent analytics, it’s not always clear
Quantum Technology Companies: patent analysis Quantum computing patent applications have increased significantly since 2009, reflecting the growing maturity and industrial relevance of the field. Patent intelligence for people who don't read patents However, for those without a background in patents, or the means to access patent analytics, it’s not always clear what
IonQ to acquire Oxford Ionics: IP play, market access—or something more? IonQ and Oxford Ionics have announced they have entered into a definitive agreement for IonQ to acquire Oxford Ionics in a transaction valued at US$1.075 billion, which will consist of US$1.065 billion in shares of IonQ common stock and approximately US$10 million in cash (subject